Maternal and perinatal outcomes in patients with COVID 19

Аннотация

Pregnant women are always at high risk of developing complications from various seasonal viral diseases. Health professionals still know little about how the virus affects the development of the foetus. Several cases of infection of the child by the coronavirus from the mother have been described, but it is very difficult to determine whether the infection has occurred in utero, during childbirth or in the first moments after birth. At the same time, no etiotropic treatment for COVID-19 in women during pregnancy and breastfeeding has been developed, as antiviral drugs are contraindicated in pregnant women. Therefore, if antivirals are required in pregnant patients in the first trimester, they are advised to terminate the pregnancy after recovery. The study of the effect of a novel coronavirus infection on perinatal outcomes appears to be an interesting research quest.